WTI (Feb) $78.39 +98c, Brent (Mar) $84.03 +$1.36, Diff -$5.64 +38c.
WTI (Feb) $78.39 +98c, Brent (Mar) $84.03 +$1.36, Diff -$5.64 +38c.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are
WTI (Mar) $80.13 -$1.49, Brent (Mar) $86.13 -$2.06, Diff -$6.00 -57c.
hVIVO (HVO) (formerly Open Orphan plc), a specialist contract research organisation, announced a trading update for the period ended 31 December 2022.
IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high-return projects, provides a corporate update in advance of the Company’s full-year
Small caps fell across the broader market, with the AIM 100 index falling 2% to 4,089 and the FTSE 100 blue chips losing 0.8% and 1.5%, respectively.
WTI (Feb) $80.18 +32c, Brent (Mar) $85.92 +$1.48, Diff -$5.74 +£1.14.
IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high-return projects, provides an update on the Southwark field development:
WTI (Feb) $78.39 +98c, Brent (Mar) $84.03 +$1.36, Diff -$5.64 +38c.
WTI (Jan) $78.29 +$2.06, Brent (Feb) $82.20 +$2.21, Diff $3.91 +1c.
OKYO Pharma (OKYO), an ophthalmology-focused bio-pharmaceutical company, announced that it has received clearance of its Investigational New Drug (IND) application from the FDA to initiate a Phase 2, first-in-human, clinical